P Simmonds

Author PubWeight™ 260.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993 6.41
2 Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996 4.05
3 A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994 4.01
4 Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 1998 3.77
5 Managing patients with lung cancer. New guidelines should improve standards of care. BMJ 1999 3.65
6 Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A 1992 3.58
7 Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992 3.37
8 HCV confirmatory testing of blood donors. Lancet 1991 3.29
9 Testing of blood donations for hepatitis C virus. Lancet 1994 3.27
10 Infection with hepatitis G virus among recipients of plasma products. Lancet 1996 3.25
11 Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995 3.10
12 Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis 2006 2.97
13 Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol 1995 2.91
14 Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol 1990 2.68
15 Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol 2001 2.62
16 Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994 2.60
17 Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology 1996 2.48
18 Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998 2.45
19 The origin of hepatitis C virus genotypes. J Gen Virol 1997 2.26
20 Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993 2.24
21 A highly divergent picornavirus in a marine mammal. J Virol 2007 2.23
22 Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet 1996 2.20
23 Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 1999 2.19
24 Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 1997 2.13
25 Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol 1997 2.07
26 HTLV-III antibody in Edinburgh drug addicts. Lancet 1985 2.03
27 Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995 2.00
28 Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005 1.98
29 No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol 2007 1.96
30 The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis 1995 1.94
31 Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS 1991 1.93
32 Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol 1997 1.88
33 Serological responses to infection with three different types of hepatitis C virus. Lancet 1991 1.73
34 Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol 2008 1.68
35 Confirmation of hepatitis C virus antibody in blood donors. J Med Virol 1993 1.68
36 Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol 1999 1.68
37 Heterosexual transmission of hepatitis C virus. Lancet 1993 1.65
38 HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998 1.65
39 Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer 2001 1.62
40 Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. J Gen Virol 2004 1.62
41 HIV-1 tropism and co-receptor use. Nature 1997 1.60
42 Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996 1.56
43 Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol 1997 1.55
44 First coitus before menarche and risk of sexually transmitted disease. Lancet 1990 1.55
45 Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis 1993 1.54
46 Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995 1.54
47 Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010 1.54
48 Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995 1.53
49 Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med 1994 1.51
50 Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis 2009 1.50
51 In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994 1.50
52 Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant 1997 1.47
53 The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill 2010 1.46
54 Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2015). Arch Virol 2015 1.45
55 Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 2000 1.44
56 Screening respiratory samples for detection of human rhinoviruses (HRVs) and enteroviruses: comprehensive VP4-VP2 typing reveals high incidence and genetic diversity of HRV species C. J Clin Microbiol 2009 1.44
57 Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997 1.43
58 Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol 1998 1.42
59 HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988 1.41
60 Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol 1995 1.41
61 Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol 1996 1.41
62 Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998 1.41
63 The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol 2011 1.40
64 Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J Clin Virol 2009 1.39
65 Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J Virol 1997 1.32
66 Human parechoviruses: biology, epidemiology and clinical significance. J Clin Virol 2009 1.30
67 TT virus--part of the normal human flora? J Infect Dis 1999 1.29
68 Prevalence of HIV and syphilis among high-risk groups in Bangladesh. AIDS 2000 1.26
69 Transmission networks and population turnover of echovirus 30. J Virol 2008 1.25
70 Use of nucleotide composition analysis to infer hosts for three novel picorna-like viruses. J Virol 2010 1.25
71 Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993 1.24
72 Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol 2001 1.24
73 The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 1997 1.23
74 Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995 1.23
75 Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis 1994 1.23
76 Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations. J Virol 1999 1.23
77 Global distribution of transfusion-transmitted virus. N Engl J Med 1998 1.19
78 The polymerase chain reaction in the diagnosis of vertically transmitted HIV infection. AIDS 1990 1.19
79 Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996 1.19
80 Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993 1.18
81 Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut 1996 1.17
82 Sequence data as evidence. Nature 1993 1.17
83 Atmospheric trends in methylchloroform and the global average for the hydroxyl radical. Science 1987 1.16
84 Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo. J Virol 2001 1.16
85 Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? Br J Cancer 2011 1.16
86 Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994 1.14
87 Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol 1996 1.14
88 Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993 1.13
89 Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill 2014 1.12
90 HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Breast Cancer Res Treat 2004 1.12
91 Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat 1996 1.11
92 Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region. J Gen Virol 1997 1.09
93 Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol 2011 1.09
94 Widespread recombination within human parechoviruses: analysis of temporal dynamics and constraints. J Gen Virol 2008 1.08
95 Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J Virol 2000 1.08
96 Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol 1997 1.07
97 Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol 1997 1.07
98 Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus. J Gen Virol 1998 1.06
99 Review: molecular epidemiology of hepatitis C virus. J Gastroenterol Hepatol 1997 1.06
100 Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology 2003 1.06
101 Detection of enterovirus viraemia in blood donors. Vox Sang 2001 1.06
102 Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis 1999 1.05
103 Distribution of TT virus (TTV), TTV-like minivirus, and related viruses in humans and nonhuman primates. Virology 2003 1.04
104 Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996 1.04
105 The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995 1.04
106 Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1. J Virol 2001 1.03
107 Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30. J Virol 2010 1.03
108 Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group. J Infect Dis 1996 1.03
109 Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 1997 1.02
110 Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. Br J Haematol 1992 1.02
111 Detection of Chlamydia trachomatis in genital swabs: comparison of commercial and in house amplification methods with culture. Sex Transm Infect 1998 1.02
112 HCV confirmatory testing of blood donors. Lancet 1992 1.02
113 Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals. J Infect 1997 1.01
114 Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 1998 1.01
115 An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 2005 1.01
116 Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994 1.00
117 Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol 1996 1.00
118 Comprehensive full-length sequence analyses of human parechoviruses: diversity and recombination. J Gen Virol 2009 1.00
119 Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis 1992 1.00
120 Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies. J Gen Virol 1998 1.00
121 Sequence variability of hepatitis C virus and its clinical relevance. J Viral Hepat 1994 0.99
122 Recombination dynamics of human parechoviruses: investigation of type-specific differences in frequency and epidemiological correlates. J Gen Virol 2010 0.99
123 High detection frequency and viral loads of human rhinovirus species A to C in fecal samples; diagnostic and clinical implications. J Med Virol 2012 0.98
124 Complete coding sequence of hepatitis C virus genotype 6a. Biochem Biophys Res Commun 1997 0.97
125 Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays. J Med Virol 1997 0.96
126 Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 1996 0.95
127 Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection? Neuropathol Appl Neurobiol 2005 0.95
128 Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis 1998 0.95
129 Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet 1995 0.94
130 Sequence diversity of TT virus in geographically dispersed human populations. J Gen Virol 1999 0.94
131 Evolutionarily conserved RNA secondary structures in coding and non-coding sequences at the 3' end of the hepatitis G virus/GB-virus C genome. J Gen Virol 2001 0.93
132 Phylogenetic analysis of GBV-C/hepatitis G virus. J Gen Virol 2000 0.92
133 Comparison of diagnostic clinical samples and environmental sampling for enterovirus and parechovirus surveillance in Scotland, 2010 to 2012. Euro Surveill 2014 0.92
134 Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Transfusion 1996 0.92
135 Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol 1994 0.91
136 Infrequent detection of TT virus infection in intravenous drug users, prostitutes, and homosexual men. J Infect Dis 1999 0.90
137 Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood 1995 0.90
138 Burden of influenza B virus infections in Scotland in 2012/13 and epidemiological investigations between 2000 and 2012. Euro Surveill 2014 0.90
139 Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat 1996 0.90
140 Frequent infection of Hylobates pileatus (pileated gibbon) with species-associated variants of hepatitis B virus in Cambodia. J Gen Virol 2005 0.89
141 Upregulation of microglia in drug users with and without pre-symptomatic HIV infection. Neuropathol Appl Neurobiol 1999 0.89
142 Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. Blood 1996 0.89
143 Enhancement of immunohistochemical detection of HIV-1 p24 antigen in brain by tyramide signal amplification. J Virol Methods 1997 0.89
144 Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening. J Med Virol 1999 0.89
145 Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand J Infect Dis 1997 0.89
146 Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env. J Gen Virol 1997 0.89
147 Acute hepatitis C infection after sexual exposure. Gut 1995 0.89
148 Hepatitis C viraemia in United Kingdom blood donors. A multicentre study. Vox Sang 1992 0.88
149 Variation of hepatitis C virus following serial transmission: multiple mechanisms of diversification of the hypervariable region and evidence for convergent genome evolution. J Gen Virol 1999 0.88
150 Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response. Blood 1996 0.88
151 The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source. AIDS Res Hum Retroviruses 1995 0.87
152 Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 1999 0.87
153 Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo. Virology 2003 0.87
154 A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. Br J Haematol 1996 0.85
155 Hepatitis C virus : types, subtypes, and beyond. Methods Mol Med 1999 0.85
156 Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. J Med Virol 1996 0.85
157 Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients. Ital J Gastroenterol Hepatol 1999 0.85
158 Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 1996 0.85
159 Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. Scand J Gastroenterol 1999 0.85
160 Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation. Vox Sang 1999 0.85
161 Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types. J Virol Methods 1995 0.83
162 A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland. Vox Sang 1999 0.83
163 Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection. Neuropathol Appl Neurobiol 2003 0.83
164 Hepatitis C infection from anti-D immunoglobulin. Lancet 1995 0.83
165 Genetic heterogeneity of HIV type 1 subtypes in Kimpese, rural Democratic Republic of Congo. AIDS Res Hum Retroviruses 1999 0.83
166 Hepatitis C virus variants and the role of genotyping. J Hepatol 1995 0.82
167 Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods. Br J Haematol 1996 0.82
168 Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent. J Viral Hepat 2008 0.81
169 A new variant of GB virus C/hepatitis G virus (GBV-C/HGV) from South Africa. Virus Res 1999 0.81
170 HCV and non-Hodgkin lymphoma. Lancet 1996 0.81
171 Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates. Thromb Haemost 1998 0.81
172 The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. J Viral Hepat 1997 0.81
173 Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype. Transfusion 1996 0.80
174 In situ polymerase chain reaction amplification of HIV-1 DNA in brain tissue. J Virol Methods 1998 0.80
175 Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. Gut 1997 0.80
176 Molecular epidemiology of norovirus in Edinburgh healthcare facilities, Scotland 2007-2011. Epidemiol Infect 2012 0.80
177 Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit. Eur J Clin Microbiol Infect Dis 2000 0.80
178 HIV clearance in an infant? Nature 1995 0.80
179 Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials. Br J Cancer 2012 0.79
180 Two new lactones with mosquito larvicidal activity from three Hortonia species. J Nat Prod 2001 0.79
181 A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4. J Immunol 2001 0.78
182 Screening blood donations for hepatitis C virus by polymerase chain reaction. Vox Sang 2000 0.78
183 High frequency of parvovirus B19 in patients tested for rheumatoid factor. BMJ 1995 0.78
184 Development of anti-interferon antibodies and breakthrough hepatitis during treatment for HCV infection in haemophiliacs. Br J Haematol 1996 0.78
185 Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study. Scand J Gastroenterol 1997 0.77
186 Failure of 2nd- and 3rd-generation HCV ELISA and RIBA to detect HCV polymerase chain reaction-positive donations. Vox Sang 1994 0.77
187 Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus. Vox Sang 2001 0.77
188 Hepatitis C virus genotypes among HCV-chronic liver disease patients in Egypt: a leading trial. J Egypt Public Health Assoc 1994 0.77
189 A comparison of polymerase chain reaction and an infectivity assay for human immunodeficiency virus type 1 titration during virus inactivation of blood components. Transfusion 1993 0.77
190 Liver biopsy findings in patients with alcoholic liver disease complicated by chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol 1995 0.76
191 The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group. Scand J Gastroenterol 1998 0.76
192 High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia. J Gastroenterol Hepatol 1998 0.76
193 Drug therapy in borderline patients. Compr Psychiatry 1984 0.76
194 Scottish experience with NAT. Transfus Med 2002 0.76
195 Comparison of hepatitis B virus subtyping of d/y determinants by radioimmunoprecipitation assay and the polymerase chain reaction. J Med Virol 1992 0.76
196 Serological Genotyping Using Synthetic Peptides Derived from the NS4 Region. Methods Mol Med 1999 0.75
197 Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group. Dis Markers 1999 0.75
198 Contamination of immunoassay controls with hepatitis C virus. Lancet 1992 0.75
199 Nosocomial hepatitis C virus infection in a renal transplantation center. Clin Microbiol Infect 2002 0.75
200 Sequence analysis of the 5' non coding region of Turkish HCV isolates: implications for PCR diagnosis. Clin Diagn Virol 1996 0.75
201 Failure to detect hepatitis A virus RNA in factor VIII concentrates using the polymerase chain reaction. Results of a preliminary study. Vox Sang 1994 0.75
202 Herpes simplex encephalitis as a complication of adjuvant chemotherapy treatment for breast cancer. Clin Oncol (R Coll Radiol) 2005 0.75
203 Molecular and regional observations related to hepatitic C virus in Egyptian blood donors. Ann Saudi Med 1993 0.75
204 Spinal cord pathology and viral burden in homosexuals and drug users with AIDS. Neuropathol Appl Neurobiol 1999 0.75
205 Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group. Scand J Infect Dis 1996 0.75
206 Conflicting advice in the care of a dying patient. Practitioner 2000 0.75
207 Absence of hepatitis A virus transmission by high-purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacs. Br J Haematol 1995 0.75
208 Femtogram detection of perfluorocarbon tracers using capillary gas chromatography-electron-capture negative ion chemical ionisation mass spectrometry. J Chromatogr 1988 0.75
209 Detection of GB virus C RNA by GBV-C LCx and two PCR assays with primers from the 5' non-coding and NS5B region. J Virol Methods 1998 0.75
210 Determination of HCV Genotypes by RFLP. Methods Mol Med 1999 0.75
211 Introduction to the DAPPLE Air Pollution Project. Sci Total Environ 2004 0.75
212 A male student at the post-graduate school for nurses. N Z Nurs J 1968 0.75